124 related articles for article (PubMed ID: 10915851)
21. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
Voss SD; Sondel PM; Robb RJ
J Exp Med; 1992 Aug; 176(2):531-41. PubMed ID: 1500859
[TBL] [Abstract][Full Text] [Related]
23. Immunogenic epitopes of the p55 chain of the IL-2 receptor. Relationships to high-affinity IL-2 binding and modulation of the p55 chain.
Wong JT; Schott E; Sabga EM; Kielpinski GG; Colvin RB
Transplantation; 1990 Mar; 49(3):587-96. PubMed ID: 1690471
[TBL] [Abstract][Full Text] [Related]
24. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
25. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo.
Suzuki H; Zhou YW; Kato M; Mak TW; Nakashima I
J Exp Med; 1999 Dec; 190(11):1561-72. PubMed ID: 10587347
[TBL] [Abstract][Full Text] [Related]
26. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
27. Identification of epitopes within beta lactoglobulin recognised by polyclonal antibodies using phage display and PEPSCAN.
Williams SC; Badley RA; Davis PJ; Puijk WC; Meloen RH
J Immunol Methods; 1998 Apr; 213(1):1-17. PubMed ID: 9671121
[TBL] [Abstract][Full Text] [Related]
28. IL-2R beta agonist P1-30 acts in synergy with IL-2, IL-4, IL-9, and IL-15: biological and molecular effects.
Eckenberg R; Moreau JL; Melnyk O; Thèze J
J Immunol; 2000 Oct; 165(8):4312-8. PubMed ID: 11035066
[TBL] [Abstract][Full Text] [Related]
29. Transient ischemia-induced changes of interleukin-2 and its receptor beta immunoreactivity and levels in the gerbil hippocampal CA1 region.
Hwang IK; Yoo KY; Kim DW; Lee HJ; Kang HY; Lee HY; Kang TC; Choi SY; Kim YS; Won MH
Brain Res; 2006 Aug; 1106(1):197-204. PubMed ID: 16814753
[TBL] [Abstract][Full Text] [Related]
30. Identification of the linear epitope for Fc-binding on the bovine IgG2 Fc receptor (boFcgamma2R) using synthetic peptides.
Zhang G; Guo J; Zhou J; Wang X; Li Q; Yang Y; Shen H; Zhao D; Zhang H; Xi J; Wang L; Qiao S; Jin X
FEBS Lett; 2006 Feb; 580(5):1383-90. PubMed ID: 16457820
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
[TBL] [Abstract][Full Text] [Related]
32. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
33. Epitope mapping of the major inner capsid protein of group A rotavirus using peptide synthesis.
Kohli E; Maurice L; Bourgeois C; Bour JB; Pothier P
Virology; 1993 May; 194(1):110-6. PubMed ID: 7683153
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells.
Suminami Y; Kashii Y; Law JC; Lin WC; Stanson J; Reichert TE; Rabinowich H; Whiteside TL
Oncogene; 1998 Mar; 16(10):1309-17. PubMed ID: 9546432
[TBL] [Abstract][Full Text] [Related]
35. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
Yu A; Malek TR
J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
[TBL] [Abstract][Full Text] [Related]
36. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
[TBL] [Abstract][Full Text] [Related]
37. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the role of the interleukin-2 receptor gamma chain in ligand binding.
Liparoto SF; Myszka DG; Wu Z; Goldstein B; Laue TM; Ciardelli TL
Biochemistry; 2002 Feb; 41(8):2543-51. PubMed ID: 11851401
[TBL] [Abstract][Full Text] [Related]
39. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
40. Expression of the interleukin 2 receptor beta chain (p75) in renal transplantation--applicability of anti-interleukin-2 receptor beta chain monoclonal antibody.
Niguma T; Sakagami K; Kawamura T; Haisa M; Fujiwara T; Kusaka S; Uda M; Orita K
Transplantation; 1991 Aug; 52(2):296-302. PubMed ID: 1831304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
